Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug